Autologous tumor cell vaccination combined with systemic CpG-B and IFN-α promotes immune activation and induces clinical responses in patients with metastatic renal cell carcinoma a phase II trial

Open Access
Authors
  • B.D. Koster
  • S.J.A.M. Santegoets
  • J. Harting
  • A. Baars
  • S.M. van Ham ORCID logo
  • R.J. Scheper
  • E. Hooijberg
  • T.D. de Gruijl
  • A.J.M. van den Eertwegh
Publication date 01-06-2019
Journal Cancer immunology and immunotherapy
Volume | Issue number 68 | 6
Pages (from-to) 1025-1035
Organisations
  • Faculty of Science (FNWI) - Swammerdam Institute for Life Sciences (SILS)
Document type Article
Note Correction. Cancer Immunology, Immunotherapy (2019) 68:1037 https://doi.org/10.1007/s00262-019-02328-6
Language English
Published at https://doi.org/10.1007/s00262-019-02320-0
Downloads
Autologous tumor cell vaccination (Final published version)
Supplementary materials
Permalink to this page
Back